Mixed allogeneic chimerism: Past, present, and prospects for the future

Transplantation

Volumn 72, Issue 8 SUPPL., 2001, Pages

  Brouha, P C R ^a   Ildstad, S T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CHIMERA; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CHIMERA; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; ISOANTIGENS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035960322     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (92)

1. Problems related to immunosuppression: Infection and malignancy occurring after solid organ transplantation
2. Why do immunosuppressed patients develop cancer?
3. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts
4. Chronic rejection: An unidentified conundrum
5. Hard graft? Future challenges in transplantation
6. Immunogenic consequences of vascular anastomoses between bovine twins
7. A human blood-group chimera
8. The use of skin grafting to distinguish between homozygotic and dizygotic twins in cattle
9. Actively acquired tolerance of foreign cells
10. Successful skin homografs after the administration of high dosage X radiation and homologous bone marrow
11. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
12. Cellular factors. Immunologic tolerance: Irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness
13. Mixed chimerism and tolerance without whole body irradiation in a large animal model
14. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys
15. Mixed allogeneic chimerism and renal allogralt tolerance in cynomolgus monkeys
16. Supralethal whole body irradiation and isologous marrow transplantation in man
17. Genetic and biological aspects of the HL-A system of human histocompatibility
18. Human marrow transplantation: An immunological perspective
19. Marrow transplantation from related donors other than HLA-identical siblings
20. Tolerance to donor-type skin in the recipient of a bone marrow allograft: Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor
21. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors
22. Macrochimerism to induce donor specific tolerance and overcome the limitations of organ transplantation
23. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities
24. Cell migration, chimerism, and graft acceptance
25. Status of microchimerism in recipients 15 years after living related kidney transplantation
26. Patterns of donor-type microchimerism after heart transplantation
27. Microchimerism and rejection in clinical transplantation
28. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance
29. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2 - B10)
30. Mixed xenogeneic chimerism (mouse+ rat→mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts
31. Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat→mouse)
32. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells
33. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents
34. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 - P1) irradiation chimeras
35. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyf-2+ T-cell in mixed allogeneic reconstitution (C57BL10/Sn + B10.D2/nSn→C57BL10/Sn)
36. Self recognition in allogeneic radiation bone marrow chimeras: A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells
37. On the thymus in the differentiation of "H-2 self-recognition" by T cells: Evidence for dual recognition
38. Restricted helper function of F1 leads to parent bone marrow chimeras controlled by K-end of H-2 complex
39. The role of H-2 linked genes in helper T-cell function. IV. Importance of T-cell genotype and host environment in Ir region and Ir-gene expression
40. Cellular and genetic control of antibody responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells
41. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras
42. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: Functional restriction to host MHC
43. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity, and genetic specificity of tolerance
44. T cell depletion for graft-versus-host disease prophylaxis: A perspective on engraftment in mice and humans
45. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing
46. Antibody-facilitated chimeras: Stem cell allotransplantation using antihost major histocompatibility complex monoclonal antibodies instead of lethal irradiation for host conditioning
47. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers
48. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
49. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
50. + cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning
51. A partial conditioning approach to achieve mixed chimerism in the rat: Depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment
52. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in non-obese diabetic (NOD) mice
53. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells
54. Allogeneic bone marrow transplantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
55. The abrogation of allosensitization following the induction of mixed allogeneic chimerism
56. The highly sensitized patient: Etiology, impact, and management
57. Influence of pretransplant allosensitization in cardiac transplant outcome
58. Graft-versus-host disease
59. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
60. Bone marrow transplantation
61. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
62. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
63. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings: A pilot study using immunotoxins for T cell depletion of donor bone marrow
64. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
65. Lymphohemopoietic reconstitution using wheat germ agglutinin-positive hemopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers
66. Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment
67. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity
68. Clonal deletion of post-thymic T cells: Veto cells kill precursor cytotoxic T lymphocytes
69. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: Potential role of a veto mechanism
70. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
71. + bone marrow subpopulation that promotes allogeneic stem cell engraftment
72. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model
73. Winning the battle of graft versus host
74. A rare find: Cells that improve bone marrow transplantation
75. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients
76. Clinical applications of mixed chimerism
77. Leukodystrophy and bone marrow transplantation: Role of mixed hematopoietic chimerism
78. Bone marrow transplantation: A natural form of gene therapy
79. Bone marrow transplantation for sickle cell disease
80. Bone marrow transplantation without myeloablation for sickle cell disease
81. Bone marrow transplantation in adult thalassemia
82. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells
83. Effective treatment of autoimmune disease and progressive renal disease by mixed bonemarrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice
84. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia
85. Apparent cure of rheumatoid arthritis by bone marrow transplantation
86. Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases?
87. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia
88. Clearance of severe psoriasis after allogeneic bone marrow transplantation
89. Preexisting autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation
90. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases
91. New opportunities for the treatment of severe autoimmune diseases: Bone marrow transplantation